Scancell company information, Employees & Contact Information

NHS signs deal with Scancell in ambitious skin cancer trial Financial Times

Scancell taps into NHS matchmaking service for cancer trial pharmaphorum

Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial Pharmaceutical Technology

Investor Update via Investor Meet Company. Investegate

NHS to launch skin cancer vaccine test in new treatment drive The Independent

Scancell: Broker raises price target after impressive cancer vaccine results Proactive Investors

Melanoma patients in England get fast-track access to cancer vaccine The Guardian

SMALL CAP IDEA: Next 18 months are key for Scancell and its melanoma vaccine This is Money

NHS programme to give melanoma patients fast-track access to skin cancer vaccine PMLiVE

NHS patients to take part in skin cancer vaccine drive The Telegraph

Scancell CEO on 2025 milestones and road ahead | AIM:SCLP, OTC:SCNLF Proactive Investors

Cancer vaccine trial to be expanded Healthcare Leader

Skin cancer patients given fast-tracked access to ‘revolutionary’ cancer vaccine trial on NHS Wired-Gov

Major skin cancer breakthrough after NHS announces 'exciting' new treatment Metro.co.uk

Scancell faces its big decision | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Scancell reports strong phase II results for melanoma immunotherapy Proactive Investors

Scancell Holdings: CEO L’Huillier Updates on SCOPE & Modi-1 Trials - ICYMI Proactive Investors

Scancell shares up 19% on melanoma trial fast-track news | AIM:SCLP, OTC:SCNLF Proactive Investors

Scancell: A rising star in oncology with upgraded prospects Proactive Investors

Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy Frontiers

Scancell gets South Africa’s approval for Covid-19 vaccines trial Clinical Trials Arena

Scancell enjoys stock bounce on back of phase 2 snapshot for DNA cancer vaccine Fierce Biotech

Scancell eyes key cancer milestones and data Proactive Investors

NHS to Fast-Track Patients to Melanoma Vaccine Trial Medscape

NHS to fast-track skin cancer vaccine trials Open Access Government

UK skin cancer patients fast-tracked into vaccine trial Anadolu Ajansı

Skin cancer patients could join Southampton vaccine project BBC

Genmab secures rights to second Scancell antibody in new million-dollar deal medwatch.com

Scancell names Dr Phil L'Huillier new CEO Proactive Investors

Is Scancell the best penny stock for me to buy today? Fool UK

Life-saving cancer vaccine soon available for thousands of NHS patients with deadly skin cancer Daily Mail

Skin cancer patients given fast-tracked access to ‘revolutionary’ cancer vaccine trial on NHS Health Tech World

Groundbreaking NHS skin cancer trials National Health Executive

Scancell Holdings plc AGM Announcement and Role within FTSE AIM Index Kalkine Media

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool Wiley Online Library

SMALL CAP IDEA: Next 18 months are key for Scancell and its melanoma vaccine MSN

Skin cancer patients will soon be able to test new NHS vaccine | ITV News ITVX

Scancell details further progress of lead immunotherapy assets Vox Markets

Companies working on blockbuster health treatments: MIDAS SHARE TIPS This is Money

SMALL CAP MOVERS: Lupus drug patent lights up the market This is Money

British company secures the patent for revolutionary new cancer vaccine The Independent

AIM’s best companies of 2025: shortlist revealed Interactive Investor

‘So lucky’ – New Milton grandad in ground-breaking cancer vaccine trial Advertiser and Times

Scancell Holdings Plc (SCLP.L) Share Price, Updates & RNS News Vox Markets

'Exciting' needle-free skin cancer vaccine trial set to launch on NHS Daily Express